17-Apr-2026
Barrington Keeps Their Buy Rating on Covista (CVSA)
TipRanks (Fri, 17-Apr 7:56 AM ET)
Covista Announces AI-Powered Classroom of the Future for Healthcare Education with Google Cloud
Business Wire (Tue, 14-Apr 6:00 AM ET)
Amelia Manning Named as the Next President of Chamberlain University
Business Wire (Mon, 13-Apr 8:00 AM ET)
Covista Announces Third Quarter Fiscal Year 2026 Conference Call
Business Wire (Tue, 7-Apr 8:00 AM ET)
Covista Expands Michael Betz's Role to Chief Growth & Innovation Officer
Business Wire (Mon, 6-Apr 8:00 AM ET)
Uplift Investors Appoints Evan Trent as Chief Strategy Officer
Business Wire (Tue, 10-Mar 8:30 AM ET)
Covista Inc is an American healthcare educator, serving more than 97,000 students and supported by a community of alumni across five accredited institutions. Through personalized, tech-enabled education powered by faculty and colleagues, it expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale.
Covista Common Shares trades on the NYSE stock market under the symbol CVSA.
As of April 17, 2026, CVSA stock price climbed to $117.91 with 216,482 million shares trading.
CVSA has a market cap of $4.07 billion. This is considered a Mid Cap stock.
Last quarter Covista Common Shares reported $503 million in Revenue and $2.43 earnings per share. This beat revenue expectation by $13 million and exceeded earnings estimates by $.24.
The top ETF exchange traded funds that CVSA belongs to (by Net Assets): IJR, VTI, IWM, VB, VBR.
CVSA support price is $113.72 and resistance is $118.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CVSA shares will trade within this expected range on the day.